Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context
Summary: Background: Patients with rheumatoid arthritis (RA) are at increased risk of developing herpes zoster (HZ). This study aimed to assess the effectiveness of recombinant zoster vaccine (RZV) in reducing both the incidence of HZ and all-cause mortality among individuals with RA. Methods: We c...
Saved in:
| Main Authors: | Ying-Li Lin, Shiow-Ing Wang, James Cheng-Chung Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | EClinicalMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537025002512 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes zóster en un niño inmunocompetente
by: Paola Andrea Torres, et al.
Published: (2019-08-01) -
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01) -
Herpes zoster (Shingles)
by: M. H. Motswaledi
Published: (2018-08-01) -
Current status of immunisation for herpes zoster
by: Anthony Lawrence Cunningham, et al.
Published: (2025-12-01) -
The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop
by: Gyneth Lourdes G. Bibera, et al.
Published: (2024-12-01)